Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Fluvoxamine may prevent severe COVID-19 onset, suggests trial

europeanpharmaceuticalreviewNovember 17, 2020

Tag: COVID-19 , fluvoxamine , SARS-CoV-2

PharmaSources Customer Service